Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
<p>Statistics from DESeq2</p>
সংরক্ষণ করুন:
| প্রধান লেখক: | Alyssa C. Flint (16676029) (author) |
|---|---|
| অন্যান্য লেখক: | Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author) |
| প্রকাশিত: |
2025
|
| বিষয়গুলি: | |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
অনুযায়ী: Alyssa C. Flint (16676029)
প্রকাশিত: (2025) -
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
অনুযায়ী: Elizabeth R. Tucker (15053624)
প্রকাশিত: (2025) -
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
অনুযায়ী: Elizabeth R. Tucker (15053624)
প্রকাশিত: (2025) -
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
অনুযায়ী: Elizabeth R. Tucker (15053624)
প্রকাশিত: (2025) -
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
অনুযায়ী: Elizabeth R. Tucker (15053624)
প্রকাশিত: (2025)